Placebo
VX12-809-104
Phase 3 small_molecule completed
Quick answer
Placebo for Cystic Fibrosis, Homozygous for the F508del CFTR Mutation is a Phase 3 program (small_molecule) at VERTEX PHARMACEUTICALS INC / MA with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VERTEX PHARMACEUTICALS INC / MA
- Indication
- Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed